Literature DB >> 28300890

Erythroplasia of Queyrat treated with topical 5-fluorouracil.

João Roberto Antônio1, Carlos Roberto Antônio1, Lívia Arroyo Trídico1, Fernanda Tomé Alves1, Ivan Rollemberg1.   

Abstract

We report a 33-year-old male patient diagnosed with erythroplasia of Queyrat. The patient had an erythematous and eroded lesion affecting more than 50% of the glans associated with bleeding and local pain. Despite previous indication of penectomy, he was successfully treated with topical 5-fluorouracil.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28300890      PMCID： PMC5324989          DOI： 10.1590/abd1806-4841.20164595

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN： 0365-0596            Impact factor:   1.896


  7 in total

1.  Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ.

Authors:  U Wieland; S Jurk; S Weissenborn; T Krieg; H Pfister; A Ritzkowsky
Journal:  J Invest Dermatol       Date:  2000-09       Impact factor: 8.551

Review 2.  Optical coherence tomography in dermatology: technical and clinical aspects.

Authors:  Thilo Gambichler; Volker Jaedicke; Sarah Terras
Journal:  Arch Dermatol Res       Date:  2011-06-07       Impact factor: 3.017

3.  A case of erythroplasia of Queyrat successfully treated with combination carbon dioxide laser vaporization and surgery.

Authors:  Y Yamaguchi; H Hata; K Imafuku; S Kitamura; H Shimizu
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-12-05       Impact factor: 6.166

4.  Erythroplasia of Queyrat refractory to photodynamic therapy.

Authors:  J-Y Park; S J Kim; Y C Kim
Journal:  Clin Exp Dermatol       Date:  2012-07-25       Impact factor: 3.470

Review 5.  Carcinoma in situ of the penis.

Authors:  G S Gerber
Journal:  J Urol       Date:  1994-04       Impact factor: 7.450

Review 6.  Review of erythroplasia of Queyrat and its treatment.

Authors:  D K Goette
Journal:  Urology       Date:  1976-10       Impact factor: 2.649

7.  Optical coherence tomography imaging of erythroplasia of Queyrat and treatment with imiquimod 5% cream: a case report.

Authors:  L Schmitz; E Bierhoff; T Dirschka
Journal:  Dermatology       Date:  2013-10-11       Impact factor: 5.366
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.